Managing Brain Metastases in the 21st Century: Treatment Options and Case Discussions
As patients with metastatic disease are enjoying improved survival, brain metastases are an increasing problem. Technologic advances as well as emerging evidence suggests that the indications for radiosurgery are increasing, and can be performed without threatening quality of life. Similarly frameless radiosurgery has made hypofractionation very feasible. Integrating surgery and systemic therapy into the management of brain metastases is also an important consideration. The session will review treatment options and available evidence, including whole brain radiation, with these other modalities, and use case based discussions to illustrate salient points regarding such options in clinical management, including difficult cases, such as salvage treatment.
This activity is available from December 12, 2017, through 11:59 p.m. Eastern time on December 11, 2020.
This activity was originally recorded at ASTRO’s 2017 Annual Meeting, September 24-27, 2017 in San Diego, CA.
This program is designed to meet the interest of radiation oncologists, radiation therapists, and radiation dosimetrists.
After this session, attendees should be able to:
- Discuss treatment options for managing brain metastases.
- Discuss the medical evidence related to various treatment options for brain metastases.
- Explain the indications and contraindications for treatment options.
- Yoshiya Yamada, MD, FRCPC is employed by Memorial Sloan Kettering Cancer Center, receives compensation/remuneration/funding from Brainlab, Center for Medical Education, Philips, Varian Medical Systems, and holds a leadership position at Chordoma Foundation.
- Eric Lin Chang, MD, FASTRO is employed at Keck School of Medicine of USC, receives compensation/remuneration/funding from Brainlab and AbbVie, and holds a leadership position at ASCO.
- John Fiveash, MD is employed at the University of Alabama at Birmingham and has no financial relationships with a commercial interest.
- Jon Kniesly, MD is employed by Weill Cornell School of Medicine and holds leadership positions at ASTRO.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.